Cellebrite DI Ltd. (CLBT)
NASDAQ: CLBT · Real-Time Price · USD
13.76
+1.13 (8.95%)
At close: Jun 26, 2026, 4:00 PM EDT
13.49
-0.27 (-1.96%)
After-hours: Jun 26, 2026, 7:56 PM EDT

Cellebrite DI Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
3,4324,4825,1671,7608421,597
Market Cap Growth
-11.91%-13.25%193.56%109.14%-47.29%21.66%
Enterprise Value
2,9214,0684,7301,471673.281,415
Last Close Price
13.7618.0322.038.664.368.02
PE Ratio
49.1958.16--7.3918.23
Forward PE
23.8532.2357.6040.3730.88-
PEG Ratio
1.211.962.280.82--
PS Ratio
6.919.4212.885.413.116.48
PB Ratio
6.649.2515.3851.4411.39-21.77
P/TBV Ratio
13.1115.9115.59-23.81-
P/FCF Ratio
21.6427.9641.8018.1861.5251.60
P/OCF Ratio
19.8925.8339.0917.2440.9044.29
EV/Sales Ratio
5.888.5511.794.532.495.75
EV/EBITDA Ratio
36.7051.9270.0734.0265.7667.94
EV/EBIT Ratio
46.1261.1883.1344.26644.90102.38
EV/FCF Ratio
18.4125.3738.2715.1949.2245.73
Debt / Equity Ratio
0.040.040.020.270.140
Debt / EBITDA Ratio
0.290.290.160.331.50-
Debt / FCF Ratio
0.140.140.090.151.12-
Net Debt / Equity Ratio
-0.80-0.86-1.30-8.44-2.282.48
Net Debt / EBITDA Ratio
-5.11-5.29-6.46-6.68-16.44-8.72
Net Debt / FCF Ratio
-2.56-2.58-3.53-2.98-12.30-5.87
Asset Turnover
0.530.580.660.690.730.70
Inventory Turnover
10.599.096.635.296.087.56
Quick Ratio
1.431.471.791.501.261.33
Current Ratio
1.541.561.921.661.421.46
Return on Equity (ROE)
14.45%19.10%-152.88%-150.08%46642.90%155.78%
Return on Assets (ROA)
5.66%7.05%9.54%7.62%0.28%3.41%
Return on Invested Capital (ROIC)
8.14%11.62%17.80%12.37%0.46%7.15%
Return on Capital Employed (ROCE)
10.81%13.79%16.88%14.01%0.60%7.72%
Earnings Yield
2.08%1.72%--13.53%5.49%
FCF Yield
4.62%3.58%2.39%5.50%1.63%1.94%
Dividend Yield
-0.00%0.00%0.00%0.00%8.66%
Payout Ratio
-0.00%0.00%0.00%0.00%140.06%
Buyback Yield / Dilution
-14.13%-19.30%-10.16%2.68%-20.96%-30.59%
Total Shareholder Return
-14.13%-19.30%-10.16%2.68%-20.96%-21.93%
SEC Filings: 10-K · 10-Q